Interim Analysis Planned News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interim Analysis Planned. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interim Analysis Planned Today - Breaking & Trending Today

Monopar Therapeutics Inc.: Monopar Announces Completion of Phase 2b Enrollment and Commencement of Phase 3 Enrollment in its VOICE Trial for Severe Oral Mucositis

Published: October 5, 2022

Interim Analysis Planned for Q1 2023WILMETTE, Ill., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary

Source: finanznachrichten.de

Related Topics:

Chandler RobinsonKimr TsuchimotoExchange CommissionMonopar Therapeutics IncInterim Analysis PlannedValidive PhaseChief ExecutivePrivate Securities Litigation Reform Act